Table 2.
CANCER TYPE | PATHWAY SCORING METHOD | CLUSTERING TYPE | SILHOUETTE CUTOFF | MCUT | PATHWAYS & MODULES USED | GROUP 1 SIZE | GROUP 2 SIZE | P-VALUE* (<0.05) |
---|---|---|---|---|---|---|---|---|
Pancreatic ductal adenocarcinoma | NTC | K-means | 0.4 | 2.5 | 5 | 64 | 38 | 0.03 |
Non-small cell lung carcinoma | GED | K-medoids | 0.67 | 50 | 44 | 35 | 47 | 0.02 |
Adult germ cell carcinoma and seminoma | GED | K-means | 0.375 | 15 | 224 | 15 | 59 | 0.02 |
Ovarian | GED | K-medoids | 0.7 | 40 | 43 | 125 | 60 | 0.01 |
Giloblastoma | GED | K-medoids | 0.475 | 25 | 363 | 48 | 32 | 0.03 |
Sub-optimally debulked ovarian | NTC | K-medoids | 0.775 | 15 | 14 | 61 | 34 | <0.01 |
Melanoma | PCA | K-medoids | NA | 10 | 74 | 285 | 185 | 0.03, 0.04 |